FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Institut für Experimentelle und Klinische Pharmakologie und Toxikologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die nicht zum Universitätsklinikum Erlangen gehören
Overview
Publications
(495)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Editorial: Status Go for Preclinical Imaging (2020)
Kuntner C, Baumann B, Tavares AAS, Heß A
Journal article
Prostaglandin E2 stimulates the epithelial sodium channel (ENaC) in cultured mouse cortical collecting duct cells in an autocrine manner (2020)
Mansley M, Niklas C, Nacken R, Mandery K, Gläser H, Fromm M, Korbmacher C, Bertog M
Journal article
Vectorial transport of the arginine derivatives asymmetric dimethylarginine (ADMA) andl-homoarginine by OATP4C1 and P-glycoprotein studied in double-transfected MDCK cells (2020)
Taghikhani EP, Maas R, Taudte V, Geßner A, Fromm M, König J
Journal article
The hyperpolarization-activated cyclic nucleotide-gated 4 channel as a potential anti-seizure drug target (2020)
Kharouf Q, Phillips AM, Bleakley LE, Morrisroe E, Oyrer J, Jia L, Ludwig A, et al.
Journal article
CENTRAL NERVOUS SYSTEM PAIN RESPONSE AND COMPONENTS OF DISEASE ACTIVITY IN RA PATIENTS AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO: A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020)
Schenker H, Rech J, Tascilar K, Hagen M, Schoenau V, Sergeeva M, Selvakumar M, et al.
Conference contribution
PREDICTION OF RESPONSE TO CERTOLIZUMAB PEGOL TREATMENT BY FUNCTIONAL MRI OF THE BRAIN: AN INTERNATIONAL, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (PRECEPRA) (2020)
Rech J, Tascilar K, Schenker H, Sergeeva M, Selvakumar M, Konerth L, Prade J, et al.
Conference contribution
LONGITUDINAL CHANGE IN THE CENTRAL NERVOUS SYSTEM PAIN RESPONSE AFTER TREATMENT WITH CERTOLIZUMAB OR PLACEBO. A POST-HOC ANALYSIS FROM THE PRECEPRA TRIAL (2020)
Rech J, Tascilar K, Schenker H, Hagen M, Sergeeva M, Selvakumar M, Konerth L, et al.
Conference contribution
Retronasal olfactory testing using candies sent by post and for screening purposes: a feasibility study (2020)
Besser G, Tianxiang Liu D, Prem B, Iabloncsik D, Pablik E, Mueller CA, Renner B
Journal article
Medication safety in intravenous therapy: A compatibility study and analysis of reaction products of dihydralazine and metamizole (2020)
Koller AK, Fischer O, Krebs S, Heinrich M, Dörje F
Journal article
Regiospecific Introduction of Halogens on the 2-Aminobiphenyl Subunit Leading to Highly Potent and Selective M3 Muscarinic Acetylcholine Receptor Antagonists and Weak Inverse Agonists (2020)
Fischer O, Hofmann J, Rampp H, Kaindl J, Pratsch G, Bartuschat A, Taudte V, et al.
Journal article
‹
1
...
11
12
13
14
15
...
34
›